Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 87 total PSOs listed by AHRQ.

American Data Network PSO - P0051
Component of Parent Org(s):
  • American Data Network
Effective Date and Time of Initial Listing: February 25, 2009 12:01 AM ET
Mailing address: 10809 Executive Center Drive, Searcy Building, Suite 300, Little Rock, AR 72211
PSO Phone Number: (501) 225-5533, ext. 103
Point of Contact: Stephanie Iorio
Point of Contact Phone: (501) 537-7942
Point of Contact Email: siorio@americandatanetwork.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 02/25/2019 through 02/24/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Ascension Healthcare Patient Safety Organization - P0111
Component of Parent Org(s):
  • Ascension
Effective Date and Time of Initial Listing: May 11, 2011 12:01 AM ET
Mailing address: 4600 Edmundson Road, St. Louis, MO 63134
PSO Phone Number: 314-733-8164
Point of Contact: Ruth Eaker
Point of Contact Phone: 314-733-8164
Point of Contact Email: Ruth.Eaker@ascension.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 05/11/2019 through 05/10/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
Clarity PSO - P0015
Component of Parent Org(s):
  • Clarity Group, Inc.
Effective Date and Time of Initial Listing: November 19, 2008 12:01 AM ET
Mailing address: 8725 W Higgins Road, Suite 810, Chicago, IL 60631
PSO Phone Number: (773) 867-8066
Point of Contact: Thomas F. Piotrowski
Point of Contact Phone: (773) 867-8066
Point of Contact Email: tpiotrowski@claritypso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/19/2018 through 11/18/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Kansas Clinical Improvement Collaborative Patient Safety Organization - P0184
Component of Parent Org(s):
  • Kansas Clinical Improvement Collaborative, LLC
Effective Date and Time of Initial Listing: December 7, 2016 12:01 AM ET
Mailing address: 2330 Shawnee Mission Parkway, Suite 300, Mail stop 5001, Westwood, KS 66205
PSO Phone Number: 913-945-7515
Point of Contact: Shelley Faye Boden
Point of Contact Phone: 785-324-1507
Point of Contact Email: shelley.boden@khsc-ku.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/07/2020 through 12/06/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Midwest Alliance for Patient Safety - P0087
Component of Parent Org(s):
  • Illinois Health and Hospital Association
Effective Date and Time of Initial Listing: April 28, 2010 12:01 AM ET
Mailing address: 1151 East Warrenville Road, Naperville, IL 60566
PSO Phone Number: 630-276-5682
Point of Contact: Carrie Pinasco
Point of Contact Phone: 630-276-5845
Point of Contact Email: cpinasco@team-iha.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/28/2020 through 04/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Pascal Metrics Inc - P0047
Effective Date and Time of Initial Listing: February 11, 2009 12:01 AM ET
Mailing address: 1025 Thomas Jefferson Street NW, Suite 420 East, Washington, DC 20007
PSO Phone Number: (202) 333-9090
Point of Contact: Alejandra Alvarez
Point of Contact Phone: (202) 333-9090
Point of Contact Email: alejandra.alvarez07@pascalmetrics.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 02/11/2019 through 02/10/2021
Disclosures & Finding: None
Patient Safety Organization of Florida (PSOFlorida) - P0052
Component of Parent Org(s):
  • Florida Hospital Association
  • South Florida Hospital and Healthcare Association, Inc.
Effective Date and Time of Initial Listing: February 25, 2009 12:01 AM ET
Mailing address: 306 East College Avenue, Tallahassee, FL 32301
PSO Phone Number: (850) 222-9800
Point of Contact: Martha DeCastro
Point of Contact Phone: (850) 222-9800
Point of Contact Email: Martha@fha.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 02/25/2019 through 02/24/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Virginia PSO - P0151
Component of Parent Org(s):
  • Virginia Hospital and Healthcare Association
  • Virginia Hospital Research and Education Foundation
Effective Date and Time of Initial Listing: September 11, 2013 12:01 AM ET
Mailing address: P.O. Box 31394, Richmond, VA 23294
PSO Phone Number: 804-965-1214
Point of Contact: Kristie Lynne Burnette
Point of Contact Phone: 804-965-1226
Point of Contact Email: kburnette@vhha.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 09/11/2019 through 09/10/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Vizient™ PSO - P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Mailing address: 155 North Wacker Drive, 40th floor, Chicago, IL 60606
PSO Phone Number: 312-775-4100
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No